Phase 4 Thyroid Cancer Trial, Recruiting NCT07600580 Sponsor: University Hospital Dubrava Condition: Thyroid Cancer
Back to Thyroid Cancer

Phase 4 Thyroid Cancer Trial, Recruiting

NCT07600580
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Both men and women are welcome to participate
  • You must be 18 years of age or older
  • You must be generally healthy or have only mild health conditions that are well controlled (confirm with trial site regarding "ASA I or II" classification)
  • Your thyroid hormone levels must be normal at the time of the study
  • You must be willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • People who do not wish to sign the consent form to participate
  • People who have an active infection at the area where an injection would be given
  • People who are allergic to or cannot take the medications being used in the study
  • People who have an underactive or overactive thyroid at the time of surgery
  • People who have a goiter (enlarged thyroid gland) that extends behind the breastbone
  • People who need additional surgical procedures done at the same time
  • People who have had previous surgery or radiation treatment on their neck
  • People who have a blood clotting disorder
  • People who have a breathing or lung condition that is not well controlled
  • People who have diabetes
  • People who have an autoimmune disease
  • People who regularly take steroid medications (such as prednisone)
  • People who smoke
  • Women who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +385996830715

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
University Hospital Dubrava
Registry
ClinicalTrials.gov
Start date
13 May 2024
Est. completion
3 February 2027

Where this trial is recruiting

🇭🇷 Croatia

Primary endpoints

Serum Cortisol Concentration; Salivary Cortisol Concentration; Serum IL-6 Concentration; Salivary IL-6 Concentration; Serum Alpha-amylase Activity; Salivary Alpha-amylase Activity; Serum CRP Concentration; Serum Glucose Concentration; Total Lukocyte Count

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov